In this study, we focused on identification of a prospective therapeutic target in two different BCSC populations (ALDH+ and CD29hi CD61+) sorted from luminal subtype cancer cells (PyMT-driven) using RNA sequencing. The gene discussed is ITGB3; the disease is cancer.